Director of the Institute of Translational Biomedicine at St. Petersburg State University.
1988 graduated from the Russian State Medical University named after Pirogov, Faculty of Medicine and Biology.
After university he worked at the Institute of Pharmacology of the Russian Academy of Medical Sciences (Moscow), dealt with the problems of psychopharmacology of the dopamine system, in 1992 he defended his Ph.D. thesis in pharmacology.
From 1996 to 2008 he conducted research at Duke University, NC, USA, where he was an Assistant Research Professor and Associate Research Professor.
From 2008 to 2016 he headed a laboratory at the Italian Institute of Technology, Genova, Italy.
From 2013 to 2018 he was a professor at Skoltech, Moscow.
Since 2013 he was the Professor at St. Petersburg State University, since 2015 - Director of the Institute of Translational Biomedicine at St. Petersburg State University.
Professional achievements and awards
Since 2013 he has been the chairman of the nomenclature committee for dopamine receptors of the World Society of Pharmacologists IUPHAR.
Raul Radikovich works in the experimental pharmacology of brain diseases using genetically modified animals as models of human diseases such as schizophrenia, depression, Parkinson's disease and attention deficit hyperactivity disorder in children (ADHD). He consults a number of international pharmaceutical companies.
He is the author of over 240 scientific articles (including publications in Science, Nature, Cell, PNAS) and 13 patents. His work has been cited over 23,000 times (Hirsch index – 74).